1. Home
  2. XBIT vs TCX Comparison

XBIT vs TCX Comparison

Compare XBIT & TCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.16

Market Cap

66.8M

Sector

Health Care

ML Signal

HOLD

Logo Tucows Inc.

TCX

Tucows Inc.

HOLD

Current Price

$10.16

Market Cap

167.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
XBIT
TCX
Founded
2005
1992
Country
United States
Canada
Employees
87
N/A
Industry
Pharmaceuticals and Biotechnology
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
66.8M
167.0M
IPO Year
2015
2005

Fundamental Metrics

Financial Performance
Metric
XBIT
TCX
Price
$2.16
$10.16
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
43.1K
64.2K
Earning Date
05-08-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$362,275,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
6.76
52 Week Low
$2.09
$8.46
52 Week High
$3.44
$25.17

Technical Indicators

Market Signals
Indicator
XBIT
TCX
Relative Strength Index (RSI) 42.52 41.14
Support Level N/A $9.51
Resistance Level $2.46 $11.09
Average True Range (ATR) 0.05 0.55
MACD -0.00 0.01
Stochastic Oscillator 23.53 11.42

Price Performance

Historical Comparison
XBIT
TCX

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

About TCX Tucows Inc.

Tucows Inc is a corporate parent, allocating capital and providing efficient shared services to its three businesses. The Company offers Mobile Service Enabler (MSE) solutions, as well as professional services to other retail mobile providers. The Company is also a distributor of Internet services, including domain name registration, digital certificates, and email. It provides these services through an Internet-based distribution network of Internet Service Providers, web hosting companies, and other providers of Internet services to end-users. It operates in three segments: Ting, Wavelo, and Tucows Domains. It generates the majority of its revenue from Tucows Domains. The company generates key revenue from Canada and USA.

Share on Social Networks: